These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1010 related items for PubMed ID: 16379016

  • 21. Are angiotensin-receptor blockers (ARBs) equivalent to or better than angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure?
    Reigle J.
    Crit Care Nurse; 2004 Dec; 24(6):67-9. PubMed ID: 15646090
    [No Abstract] [Full Text] [Related]

  • 22. Have angiotensin receptor blockers lived up to expectations?
    Fitchett D.
    Can J Cardiol; 2005 May 15; 21(7):569-75. PubMed ID: 15940354
    [Abstract] [Full Text] [Related]

  • 23. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA.
    J Renin Angiotensin Aldosterone Syst; 2002 Jun 15; 3(2):66-71. PubMed ID: 12228845
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
    Scow DT, Smith EG, Shaughnessy AF.
    Am Fam Physician; 2003 Nov 01; 68(9):1795-8. PubMed ID: 14620599
    [Abstract] [Full Text] [Related]

  • 25. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D.
    Acta Med Croatica; 2004 Nov 01; 58(2):129-34. PubMed ID: 15208798
    [Abstract] [Full Text] [Related]

  • 26. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 01; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 27. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Singh RK, Barker S.
    Curr Opin Investig Drugs; 2005 Mar 01; 6(3):269-74. PubMed ID: 15816503
    [Abstract] [Full Text] [Related]

  • 28. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 01; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 29. Renin-angiotensin system modulation: the weight of evidence.
    Brown B, Hall AS.
    Am J Hypertens; 2005 Sep 01; 18(9 Pt 2):127S-133S. PubMed ID: 16125049
    [Abstract] [Full Text] [Related]

  • 30. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM, Böhm M.
    Ther Adv Cardiovasc Dis; 2008 Jun 01; 2(3):167-77. PubMed ID: 19124420
    [Abstract] [Full Text] [Related]

  • 31. Clinical studies on the therapy of heart failure using ACE-inhibitors and AT1-receptor blockers--does combination treatment make sense?
    Hennig L.
    Clin Nephrol; 2002 Jul 01; 58 Suppl 1():S7-11. PubMed ID: 12227730
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun 01; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 33. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):726-33. PubMed ID: 16487836
    [Abstract] [Full Text] [Related]

  • 34. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure.
    Erhardt LR.
    Int J Clin Pract; 2005 May 21; 59(5):571-8. PubMed ID: 15857354
    [Abstract] [Full Text] [Related]

  • 35. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M, Ménard J.
    Circulation; 2004 Jun 01; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract] [Full Text] [Related]

  • 36. Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
    Mann DL, Deswal A.
    N Engl J Med; 2003 Nov 13; 349(20):1963-5. PubMed ID: 14610159
    [No Abstract] [Full Text] [Related]

  • 37. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Nov 13; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 38. ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure.
    Gold JA, Rahko PS.
    WMJ; 2004 Nov 13; 103(1):71-2. PubMed ID: 15101473
    [No Abstract] [Full Text] [Related]

  • 39. Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    Böhm M.
    Am J Cardiol; 2007 Aug 06; 100(3A):38J-44J. PubMed ID: 17666197
    [Abstract] [Full Text] [Related]

  • 40. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP, Rumley A, Lowe GD, McMurray JJ.
    Thromb Haemost; 2001 Dec 06; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.